FH4=STAP1. Another Gene for Familial Hypercholesterolemia?: Relevance to Cascade Testing and Drug Development?

Circulation Research - United States
doi 10.1161/circresaha.114.304801
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Evaluation of the Role of STAP1 in Familial Hypercholesterolemia

Scientific Reports
Multidisciplinary
2019English

Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia

Current Atherosclerosis Reports
Cardiovascular MedicineCardiology
2016English

Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2014English

LDL-apheresis Depletes apoE-HDL and Pre-Β1-HDL in Familial Hypercholesterolemia: Relevance to Atheroprotection

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2011English

Treatment of Homozygous Familial Hypercholesterolemia: Challenges and Latest Development

2016English

Genetic Variation at the ApoA-IV Gene Locus and Response to Diet in Familial Hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
1998English

Familial Hypercholesterolemia: Awareness, Appraisal, and Action

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Homozygous Familial Hypercholesterolemia “Rare Disease”

Journal of Glycomics & Lipidomics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy